No Picture
News

Salk promotes three leading scientists in the fields of infectious disease, neurobiology and biological networks

LA JOLLA?Three Salk Institute faculty members have been promoted after the latest round of faculty reviews determined they are scientific leaders who have made original, innovative and notable contributions to biological research.
The post Salk promote… […]

No Picture
News

CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics,?an innovative biotechnology company focusing on research and production of wellness compounds, announced the closing of the first round of equity funding for its research projects. The company raised $7.5 M?… […]

No Picture
News

Cidara Therapeutics Highlights New Data from Multiple Rezafungin Studies Presented at ECCMID 2019

SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, highlighted new data from multiple studies of rezafungin, the company?s lead investigational compo… […]

No Picture
News

ACEA Biosciences ? A Part of Agilent Launches the xCELLigence RTCA ePacer to improve the Quality and Functionality of hiPSC-Cardiomyocytes for Drug Discovery, Safety Pharmacology, and Cardiac Disease Research

SAN DIEGO–(BUSINESS WIRE)–On March 11, 2019, ACEA Biosciences ? A Part of Agilent unveiled the new xCELLigence? RTCA ePacerTM during their workshop held at the Society of Toxicology (SOT) Annual Meeting in Baltimore. Human induced pluripotent stem ce… […]

No Picture
News

Cidara Therapeutics Selects First Clinical Development Candidate from its Cloudbreak Influenza (Antiviral) Program

SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the company has selected the antiviral conjugate (AVC) CB-012 as its first cl… […]

No Picture
News

Alnylam Initiates ILLUMINATE-B Phase 3 Pediatric Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 and Presents New Positive Results from Phase 2 Open-Label Extension Study

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc.?(Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the Company has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcu… […]

No Picture
News

Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development Agreement to Develop iPSC-based Diabetes Treatment

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24Cell&src=ctag" target="_blank"gt;$Celllt;/agt; lt;a href="https://twitter.com/hashtag/Allele_Biotech?src=hash" target="_blank"gt;#Allele_… […]

No Picture
News

ACADIA Pharmaceuticals Supports Parkinson?s Disease Awareness Month and World Parkinson?s Day with Local Educational Initiatives and Community Events Across the Country

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Parkinsons?src=hash" target="_blank"gt;#Parkinsonslt;/agt;–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and co… […]

No Picture
News

California Life Sciences Association (CLSA) and Congressman Scott Peters Announce Support for New Legislation to Repeal Medical Device Tax

WASHINGTON & SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/California?src=hash" target="_blank"gt;#Californialt;/agt;–California Life Sciences Association (CLSA), the trade association r… […]